Co-activation: its association with weakness and specific neurological pathology

BACKGROUND: Net agonist muscle strength is in part determined by the degree of antagonist co-activation. The level of co-activation might vary in different neurological disorders causing weakness or might vary with agonist strength. AIM: This study investigated whether antagonist co-activation chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Busse, Monica E, Wiles, Charles M, van Deursen, Robert WM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665451/
https://www.ncbi.nlm.nih.gov/pubmed/17116259
http://dx.doi.org/10.1186/1743-0003-3-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665451/
https://www.ncbi.nlm.nih.gov/pubmed/17116259
http://dx.doi.org/10.1186/1743-0003-3-26

Ejemplares similares